The price of Actinium Pharmaceuticals Inc (AMEX: ATNM) closed at $7.83 in the last session, down -1.39% from day before closing price of $7.94. In other words, the price has decreased by -$0.11 from its previous closing price. On the day, 556136 shares were traded.
Ratios:
We take a closer look at ATNM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.87 and its Current Ratio is at 9.87. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, HSBC Securities on September 06, 2023, initiated with a Buy rating and assigned the stock a target price of $11.60.
On September 08, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $20.Cantor Fitzgerald initiated its Overweight rating on September 08, 2022, with a $20 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATNM now has a Market Capitalization of 217.39M and an Enterprise Value of 136.63M. Its current Enterprise Value per Revenue stands at 1.06k whereas that against EBITDA is -2.62.
Stock Price History:
Over the past 52 weeks, ATNM has reached a high of $9.86, while it has fallen to a 52-week low of $4.00. The 50-Day Moving Average of the stock is 6.69, while the 200-Day Moving Average is calculated to be 6.18.
Shares Statistics:
According to the various share statistics, ATNM traded on average about 314.16K shares per day over the past 3-months and 932.64k shares per day over the past 10 days. A total of 27.76M shares are outstanding, with a floating share count of 26.69M. Insiders hold about 3.88% of the company’s shares, while institutions hold 24.41% stake in the company. Shares short for ATNM as of Mar 15, 2024 were 1.82M with a Short Ratio of 5.80, compared to 1.86M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.57% and a Short% of Float of 6.57%.
Earnings Estimates
The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.54 for the current quarter, with a high estimate of -$0.48 and a low estimate of -$0.61, while EPS last year was -$0.43. The consensus estimate for the next quarter is -$0.61, with high estimates of -$0.57 and low estimates of -$0.65.
Analysts are recommending an EPS of between -$1.97 and -$2.11 for the fiscal current year, implying an average EPS of -$2.05. EPS for the following year is -$1.86, with 6 analysts recommending between -$1.44 and -$2.66.
